I took these notes, they're a bit unclear, sorry about that:
possible measures
OCT
thickness of nerve muscle bundles
exercise performances
walking times
cerebral perfusion
funding, multidisciplinary engagement, not going to be a perfect trial (Not knowing right time frame, right objective measurements),
time is of the essence
accelerated cycle time
demonstrate proof of principle
short cycles because we don't know how long treated vein stays open (near term, helps us gain information, what parameters are changing, gives ms patients some confidence)
primary effectiveness: multifunctional composite (upper and lower extremity) MFSC with additional cognitive component
secondary effectiveness: what he'd said at the start of the video (other objectives)
then forge larger trials (multi center or societal based)
pilot study with three month follow –up, take data to larger study. what number of patients have renarrowing, other potential options incluidng stents for more durable
mehta says 3 months is too short, 6mos to year better
why certain patients respond and others don't
larger trials may have sponsors
gov't grants, societal grants, insurance (venous compression code).
ms patients network extremely well and we'll know

if in a sham
financial backing
NIH as possible sponsor
mehta on surgical reconstruction of veins, not enough evidence yet, but in extrapolating from angioplasty data and experiences
histological data: why are thse veisn at certain places getting stenoses
ccsvi is moving fast, societies are devoting blocks of time at annual meetings, FSIR
opportunity to work with people from different disciplines